Reply: Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?

Sylvie Bannwarth, Samira Ait-El-Mkadem, Annabelle Chaussenot, Emmanuelle C. Genin, Sandra Lacas-Gervais, Konstantina Fragaki, Laetitia Berg-Alonso, Yusuke Kageyama, Valerie Serre, David Moore, Annie Verschueren, Cecile Rouzier, Isabelle Le Ber, Gaëlle Auge, Charlotte Cochaud, Françoise Lespinasse, Karine N'Guyen, Anne De Septenville, Alexis Brice, Patrick Yu-Wai-ManHiromi Sesaki, Jean Pouget, Veronique Paquis-Flucklinger

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e386
JournalBrain
Volume138
Issue number10
DOIs
StatePublished - Oct 1 2015

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Bannwarth, S., Ait-El-Mkadem, S., Chaussenot, A., Genin, E. C., Lacas-Gervais, S., Fragaki, K., Berg-Alonso, L., Kageyama, Y., Serre, V., Moore, D., Verschueren, A., Rouzier, C., Le Ber, I., Auge, G., Cochaud, C., Lespinasse, F., N'Guyen, K., De Septenville, A., Brice, A., ... Paquis-Flucklinger, V. (2015). Reply: Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis? Brain, 138(10), e386. https://doi.org/10.1093/brain/awv116